Ardent Health Partners Inc (NYSE: ARDT) has seen a rise in its stock price by 6.62 in relation to its previous close of 16.00. However, the company has experienced a 6.16% gain in its stock price over the last five trading sessions. businesswire.com reported 2024-08-14 that BRENTWOOD, Tenn.–(BUSINESS WIRE)–Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Summary (All comparisons versus the same prior year period, unless otherwise noted) Total revenue of $1.47 billion, an increase of 7.5% Net income of $67 million Net income attributable to Ardent Hea.
Is It Worth Investing in Ardent Health Partners Inc (NYSE: ARDT) Right Now?
Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for ARDT is 10.41M and currently, short sellers hold a 3.41% of that float. On August 15, 2024, ARDT’s average trading volume was 542.51K shares.
ARDT’s Market Performance
The simple moving average for the last 20 days is 2.16% for ARDT stock, with a simple moving average of 2.16% for the last 200 days.
Analysts’ Opinion of ARDT
Many brokerage firms have already submitted their reports for ARDT stocks, with Truist repeating the rating for ARDT by listing it as a “Buy.” The predicted price for ARDT in the upcoming period, according to Truist is $21 based on the research report published on August 12, 2024 of the current year 2024.
Stephens, on the other hand, stated in their research note that they expect to see ARDT reach a price target of $24. The rating they have provided for ARDT stocks is “Overweight” according to the report published on August 12th, 2024.
RBC Capital Mkts gave a rating of “Outperform” to ARDT, setting the target price at $23 in the report published on August 12th of the current year.
ARDT Trading at 2.16% from the 50-Day Moving Average
After a stumble in the market that brought ARDT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -6.06% of loss for the given period.
During the last 5 trading sessions, ARDT rose by +2.43%, in comparison to the 20-day moving average, which settled at $16.72. In addition, Ardent Health Partners Inc saw 6.23% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for ARDT
Current profitability levels for the company are sitting at:
- 0.05 for the present operating margin
- 0.97 for the gross margin
The net margin for Ardent Health Partners Inc stands at 0.01. The total capital return value is set at 0.04.
Based on Ardent Health Partners Inc (ARDT), the company’s capital structure generated 0.63 points at debt to capital in total, while cash flow to debt ratio is standing at 0.01. The debt to equity ratio resting at 1.69. The interest coverage ratio of the stock is 3.56.
Currently, EBITDA for the company is 370.35 million with net debt to EBITDA at 9.71. When we switch over and look at the enterprise to sales, we see a ratio of 1.58. The receivables turnover for the company is 3.59for trailing twelve months and the total asset turnover is 0.6. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.79.
Conclusion
To wrap up, the performance of Ardent Health Partners Inc (ARDT) has been better in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
